Architect System
Device
Abbott Laboratories
Total Payments
$4.5M
Transactions
34
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $4.5M | 34 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.5M | 34 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluation of Cardiovascular Biomarkers in the Randomized Evaluation of the Effects of Anacetrapib Through Lipid-modification (REVEAL) TIMI-55 | Abbott Laboratories | $3.6M | 0 |
| Atherosclerosis Risk in Communities (ARIC) | Abbott Laboratories | $422,796 | 0 |
| Evaluation of Cardiovascular Biomarkers in the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (Fourier TIMI 59) | Abbott Laboratories | $132,200 | 0 |
| WYOMING Clinical Specimen Collection Protocol for Evaluation of Abbott Laboratories in Vitro Diagnostic Assays | Abbott Laboratories | $95,278 | 0 |
| CMR Impact Abbott Ancillary Study | Abbott Laboratories | $84,084 | 0 |
| Dried Blood Spots Study | Abbott Laboratories | $71,749 | 0 |
| Human Specimen Collection | Abbott Laboratories | $40,000 | 0 |
| Surveillance of Covid-19 exposures during early pregnancy in Rhode Island | Abbott Laboratories | $31,391 | 0 |
| MultIethNic Study of BrEast ARterial Calcium Gradation and CardioVAscular Disease Biomarkers Sub-study | Abbott Laboratories | $30,000 | 0 |
| Abbott Brainstorm Medical Phase I data analysis protocol | Abbott Laboratories | $25,000 | 0 |
Top Doctors Receiving Payments for Architect System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $4.5M | 34 |
Ad
Manufacturing Companies
- Abbott Laboratories $4.5M
Product Information
- Type Device
- Total Payments $4.5M
- Total Doctors 0
- Transactions 34
About Architect System
Architect System is a device associated with $4.5M in payments to 0 healthcare providers, recorded across 34 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $4.5M was paid across 34 transactions to 0 doctors.
The most common payment nature for Architect System is "Unspecified" ($4.5M, 100.0% of total).
Architect System is associated with 10 research studies, including "Evaluation of Cardiovascular Biomarkers in the Randomized Evaluation of the Effects of Anacetrapib Through Lipid-modification (REVEAL) TIMI-55" ($3.6M).